Bepreve Solution/ Drops
Pricing Report NDC 24208-629-01

Latest NADAC: $53.81112 per ML · Effective Jan 01, 2025
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Bepreve (NDC 24208-629-01) is $53.81112 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 01, 2025.

As a a human prescription drug provided by Bausch & Lomb Incorporated, this medication is distributed in a 1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$53.81112
Per ML

Pricing Unit
Per ML Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jan 01, 2025
Data Status
As of Jan 14, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
24208-629-01
Description
1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER
Generic Benchmark
The generic equivalent rate is $14.63491 (Effective: Dec 17, 2025)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2014, the NADAC wholesale price for (NDC ) has moved within a range of $27.79713 to $56.01227 per ML. Over this 11 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$27.7971 - $55.9887
Market Volatility
101.42% Variance
Latest Trend
0.09%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Mar 18, 2026 $55.93567 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Mar 18, 2026 $55.93567 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Mar 18, 2026 $55.93567 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Mar 18, 2026 $55.93567 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Mar 18, 2026 $55.93567 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Mar 18, 2026 $55.93567 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Feb 18, 2026 $55.98867 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Dec 17, 2025 $55.98867 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Dec 17, 2025 $55.98867 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Nov 19, 2025 $55.98867 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $55.98867 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $55.98867 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026